06-19-2020, 02:32 PM
(06-19-2020, 12:37 PM)divmenow Wrote:I wouldn't even try to tell you that. Forward PE is about 10 and that is with some flat quarters projected near term (which I expect may come true). BMY is a better value than most of the sector. I've had 2-3 puts sold against it for months. That would be 200-300 more shares which is a lot for me so I am a believer. The income has been nice but another week or so of this and I am just going to go for it and buy the extra shares. For now I just add 10 here and there. I got lucky and caught it 2 cents from the bottom today. I was waiting around for the DEMs to hate on pharma, (Trump isn't exactly a fan either). They are distracted for now though. I'll be surprised if BMY isn't good for 20% return in the next 12 months. IMO better risk reward than practically anything in my port right now. It should be my largest position and it may be soon enough.(06-19-2020, 10:50 AM)fenders53 Wrote:You cant tell me BMY isn't better then UAL, CCL, and all those other dogs that are making no money and yet going up daily. I will take my chances with BMY and the bright future they have. CELG and BMY = Long term money $$ maker(06-19-2020, 09:13 AM)divmenow Wrote: Not adding any new names. But I did add to BMY which is in my top 10 lol. But wow this has been a POS of late lol
A lot of the big pharma stocks are flat. It's probably a sector thing. Elective procedures are still dead. That explains the companies with Med device exposure which is most of the majors. Probably need to get a bad quarter out of the way.